Page 4 - கார்ஸ்டன் க்ளீன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கார்ஸ்டன் க்ளீன். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கார்ஸ்டன் க்ளீன் Today - Breaking & Trending Today

Investegate |F. Hoffmann-La Roche Ltd Announcements | F. Hoffmann-La Roche Ltd: Roche presents latest advances with immunotherapies in non-Hodgkin lymphoma


Roche presents latest advances with immunotherapies in non-Hodgkin lymphoma
Data for investigational CD20xCD3 bispecific antibodies and new combination regimens with
Polivy
showed enhanced clinical benefits for people with non-Hodgkin lymphoma in early studies
Basel, 4 June 2021 ‒ Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new data on its investigational CD20xCD3 T-cell engaging bispecific antibodies, mosunetuzumab and glofitamab, and its first-in-class anti-CD79b antibody-drug conjugate, Polivy® (polatuzumab vedotin), in non-Hodgkin lymphoma (NHL) will be presented at the 2021 ASCO Annual Meeting from 4-8 June 2021.
“People with difficult-to-treat blood cancers such as non-Hodgkin lymphoma still need more options to help improve outcomes,” said Levi Garraway, M.D., Ph.D., Roche’s Chief Medical Officer and Head of Global Product Development. “We are encouraged by promising data from our emerging T-cell engaging bispecific antibodies, m ....

United States , Nathalie Meetz , Levi Garraway , Carlo Stella , Mabthera Rituxan , Patrick Barth , Gazyva Gazyvaro , Karsten Kleine , International Prognostic Index , Drug Administration , Head Of Global Product Development , Drug Administration Breakthrough Therapy Designation , Roche Group , Pharmaceuticals Industry , Roche Group Media Relations , Chief Medical Officer , Global Product , Nonproprietary Naming , Biological Products Guidance , World Health Organization Model Lists , Essential Medicines , Dow Jones Sustainability Indices , Chugai Pharmaceutical , Investegate Announcements , Investegate Company Announcements , F Hoffmann La Roche Ltd ,